Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
Status: | Recruiting |
---|---|
Conditions: | Breast Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/2/2016 |
Start Date: | October 2008 |
Contrast-enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
RATIONALE: Diagnostic procedures, such as contrast-enhanced MRI, may help find and diagnose
ductal carcinoma in situ.
PURPOSE: This randomized clinical trial is studying contrast-enhanced MRI in women with
ductal breast carcinoma in situ and in healthy volunteers.
ductal carcinoma in situ.
PURPOSE: This randomized clinical trial is studying contrast-enhanced MRI in women with
ductal breast carcinoma in situ and in healthy volunteers.
OBJECTIVES:
- To compare ductal carcinoma in situ (DCIS)-optimized MRI with standard clinical MRI, in
terms of conspicuity of DCIS lesion, agreement of disease extent with biopsy, and
overall image quality (i.e., artifact level, uniformity of fat suppression, contrast to
noise ratio and signal to noise ratio), in women with DCIS of the breast.
- To compare two DCIS-optimized MRIs for variability in enhancement levels for DCIS.
- To examine the effect of the menstrual cycle on the variability of background
enhancement levels in healthy volunteers.
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 arms.
- Arm I: Patients undergo standard clinical contrast-enhanced MRI over approximately
30-45 minutes. No more than 3 days later, patients undergo ductal carcinoma in situ
(DCIS)-optimized contrast-enhanced MRI.
- Arm II: Patients undergo DCIS-optimized contrast-enhanced MRI over approximately 30-45
minutes. No more than 3 days later, patients undergo a second DCIS-optimized
contrast-enhanced MRI.
Healthy volunteers undergo DCIS-optimized contrast-enhanced MRI as in arm II.
- To compare ductal carcinoma in situ (DCIS)-optimized MRI with standard clinical MRI, in
terms of conspicuity of DCIS lesion, agreement of disease extent with biopsy, and
overall image quality (i.e., artifact level, uniformity of fat suppression, contrast to
noise ratio and signal to noise ratio), in women with DCIS of the breast.
- To compare two DCIS-optimized MRIs for variability in enhancement levels for DCIS.
- To examine the effect of the menstrual cycle on the variability of background
enhancement levels in healthy volunteers.
OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 arms.
- Arm I: Patients undergo standard clinical contrast-enhanced MRI over approximately
30-45 minutes. No more than 3 days later, patients undergo ductal carcinoma in situ
(DCIS)-optimized contrast-enhanced MRI.
- Arm II: Patients undergo DCIS-optimized contrast-enhanced MRI over approximately 30-45
minutes. No more than 3 days later, patients undergo a second DCIS-optimized
contrast-enhanced MRI.
Healthy volunteers undergo DCIS-optimized contrast-enhanced MRI as in arm II.
DISEASE CHARACTERISTICS:
- Meets 1 of the following criteria:
- Patient at the University of California, San Francisco Breast Care Center
meeting the following criteria:
- Biopsy proven ductal carcinoma in situ (DCIS) of the breast
- Has undergone mammography within the past 60 days
- Healthy volunteer
- No prior breast disease
PATIENT CHARACTERISTICS:
- Not pregnant or nursing (or stopped nursing within the past 3 months)
- Negative pregnancy test
- No contraindication to MRI (e.g., implanted pacemaker, implanted ferromagnetic
device, ferromagnetic aneurysm clip, severe claustrophobia, ocular metal fragments,
or shrapnel injury)
PRIOR CONCURRENT THERAPY:
- More than 2 years since prior surgery to the ipsilateral breast (patient)
- No prior radiotherapy to the ipsilateral breast (patient)
- No prior cytotoxic regimens (patient)
We found this trial at
1
site
1600 Divisadero Street
San Francisco, California 94115
San Francisco, California 94115
888.689.8273
UCSF Helen Diller Family Comprehensive Cancer Center UCSF’s long tradition of excellence in cancer research...
Click here to add this to my saved trials